Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 100 for “"Platinum compounds"”.
-
Toxicity of Novel Platinum Compounds in Mammalian Cancer Cells
There are currently three FDA platinum compounds approved for use as chemotherapeutics, where each drug has variable efficacies for different cancer types depending on cancer’s tissue of origin. The approved compounds are platinum(II) complexes with four coordination sites on the platinum atom …
-
Mechanisms of Accumulation and Biological Consequences of Polynuclear Platinum Compounds
… and cellular uptake than clinical anticancer platinum drugs such as cisplatin, oxaliplatin and carboplatin. The clinical efficacy of cisplatin, oxaliplatin and carboplatin is limited due to acquired resistance and dose limiting side effects. The three major pharmacological factors contributing …
-
A Study on the Protein Interaction with Different Platinum Compounds
… metastatic or advanced cancer with cisplatin and platinum compounds. Platinum compounds covalently bind to DNA and disrupt DNA function. They are also known to bind with amino acids like methionine, histidine and cysteine to form cisplatin-protein adducts which are responsible for most of its …
-
Host intervention and eradication of the Ascites sarcoma-180 in mice treated with platinum compounds
Thesis (M.S.)--Michigan State University. Dept. of Pathology, 1975
-
Development of Non-Traditional Platinum Anticancer Agents: trans-Platinum Planar Amine Compounds and Polynuclear Platinum Compounds
Development of Non-Traditional Platinum Anticancer Agents: trans-Platinum Planar Amine Compounds and Polynuclear Platinum Compounds By Daniel E. Lee, Ph.D. A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy at Virginia Commonwealth University. …
-
ELECTROSPRAY IONIZATION MASS SPECTROMETRY FOR THE CHARACTERIZATION OF COVALENT AND NONCOVALENT POLYNUCLEAR PLATINUM COMPOUNDS INTERACTING WITH BIO-MOLECULES
Polynuclear platinum compounds represent a new class of potential platinum anticancer therapeutics. Derived from the most widely used platinum anticancer drug, cisplatin, these novel compounds are distinct in their interactions with bio-molecules. The effectiveness of platinum anticancer agents is …
-
Molecular effects of tumor-inhibiting platinum compounds in mammalian cells in vitro : investigations into their possible mechanisms of action
Thesis (Ph. D.)--Michigan State University. Department of Biophysics, 1970
-
Drug Design, Biological Activity, and Metabolic Consequences of Cytotoxic Platinum Compounds: Utilizing Fluorescent Tagging to Understand Drug Action and Metabolism
Platinum drugs are among the most commonly used chemotherapeutics for the treatment of testicular, head and neck, ovarian, small cell lung, and colorectal carcinomas. Although the current set of platinum chemotherapeutics has proven somewhat successful, the overall success of platinum based drugs …
-
CYTOTOXIC PROPERTIES OF NOVEL PLATINUM COMPOUNDS, BBR3610-DACH AND TRANS-4-NBD IN TUMOR CELLS: CELLULAR EFFECTS OF 1, 2-DACH AND NBD LIGANDS
Platinum-based chemotherapeutics are used for the treatment of a wide range of cancers and a number of attempts have been made toward developing compounds with better cellular stability and similar or enhanced cytotoxicity as compared to their predecessors. The first part of the work reported here …
-
Activity of Analogs of Anticancer Drugs on the Serine Protease Enzymes Subtilisin and Chymotrypsin
The anticancer activity of several platinum compounds is due to the formation of complexes with DNA. We hypothesize that the size and shape of the platinum compounds would impact interaction with proteins, and these interactions may be partly responsible for the anticancer activity. Chymotrypsin …
-
Investigating the Apoptotic Effects of Platinum(II) Amine Complexes With Only One Leaving Ligand on Zebrafish Auditory End Organs
The FDA-approved platinum compound, cisplatin, is commonly used as a chemotherapy drug to treat many forms of cancer. However, this compound also has several associated side-effects, including ototoxicity. This has made the development of novel platinum compounds that reduce cancer cell viability, …
-
Pre-Treatment with BET Inhibitors Increases the Sensitivity of Cancer Cell Lines to Cisplatin and Oxaliplatin
Platinum compounds, such as cisplatin, carboplatin and oxaliplatin are utilised widely in therapeutic strategies against a range of malignancies, for instance Neuroblastoma and Ovarian cancer. These compounds elicit anticancer effects by damaging DNA via the formation of crosslinks with nitrogenous …
-
Effect of Leaving Ligands of Platinum(II) Diamine Complexes on DNA and Protein Residues
Platinum compounds are widely used drugs in cancer treatments. Although DNA is the biological target, reaction of platinum compounds with proteins is also potentially significant. Our objective is to study the effects of leaving ligands on the relative reactivity between 5'-GMP (guanosine 5' …
-
Platinum Induced Nucleolar Stress: A study of Molecular Level Factors
Platinum anti-cancer drugs are widely used in the United States being used in 10-20% of cancer therapy treatments today. These drugs have been in use for many years with cisplatin being in use for over 40 years. The mechanism of platinum compounds was believed to be through the DNA damage response …
-
Cellular Toxicity of Malonato (Ethylenediamine) Platinum (II) In Models of Cancer
Platinum(II) compounds including the three FDA approved drugs, cisplatin, carboplatin, and oxaliplatin, are composed of two structural components, a leaving ligand, and a non-leaving ligand, each attached to a central platinum(II) atom. All bifunctional platinum compounds studied have similar …
-
Relationships between neurotoxicity, accumulation, and physiochemical properties of a series of platinum drugs
Peripheral neurotoxicity induced by some platinum chemotherapy agents is the dose limiting factor, seriously affecting the quality of life of chemotherapy patients who receive this treatment. The cause of the peripheral neurotoxicity remains unknown. Using an animal model, the neurotoxic profiles …
-
Enhancing Blue Phosphorescence in Platinum Complexes with Strong σ-Donor Acyclic Diaminocarbenes
Platinum acetylide complexes, oligomers, and polymers are highly valued in a range of photochemical and optoelectronic applications, including OLEDs, optical limiting materials, photovoltaic devices, photocatalysis, and stimuli-responsive materials, due to their diverse photophysical properties. …
-
Novel cisplating analogs: Synthesis, characterization and cytotoxicity in breast cells
Cis-diamminedichloroplatinum (II) (cisplatin) has been used for three decades as an anti-cancer treatment, but is limited in its therapeutic uses by side effects and cell resistance. In this study, new cisplatin analogues were developed, synthesized, and evaluated for cytotoxicity and cellular …
Page 1 of 5